ABEO
Abeona Therapeutics
$4.55
+$0.10 (+2.25%)Oct 28, 2026
Key metrics
The numbers that frame ABEO today
- Market cap
- $260.19M
- Gross margin
- 67.1%
- EV / Sales
- 8.8
- ROIC
- -56.2%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $4.00
- 52wk High
- $7.65
Growth
Revenue and earnings trend for ABEO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ABEO
Is Abeona Therapeutics a good buy?
No. Abeona Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Abeona Therapeutics is selling at a very high price.
What is the market capitalization of ABEO?
Abeona Therapeutics's market capitalization is $260.19M.
What is the 52-week high for ABEO stock?
The 52-week high for Abeona Therapeutics is $7.65. The current close of $4.55 is 40.5% below that high.
What is the 52-week low for ABEO stock?
The 52-week low for Abeona Therapeutics is $4.00. The current close of $4.55 is 13.7% above that low.
Does ABEO stock pay dividends?
Abeona Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ABEO?
Abeona Therapeutics's Debt / Equity ratio is 0.16.